Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential

Regenerative Stromal Cell Therapy in Allogeneic Hematopoietic Stem Cell Transplantation: Current Impact and Future Directions

(2009) Jeffery J. Auletta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells

(2009) H. Samuelsson et al.   CYTOTHERAPY

HSCT Recipients Have Specific Tolerance to MSC but not to the MSC Donor

(2009) Mikael Sundin et al.   JOURNAL OF IMMUNOTHERAPY

ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring—even in hands of ELISPOT-inexperienced investigators

(2009) W. Zhang et al.   Journal of Immunotoxicology

Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans

(2009) Lingyun Sun et al.   STEM CELLS

Fibroblast Growth Factor-2 Enhances Proliferation and Delays Loss of Chondrogenic Potential in Human Adult Bone-Marrow-Derived Mesenchymal Stem Cells

(2009) Luis A. Solchaga et al.   TISSUE ENGINEERING PART A

Impact of graft-versus-host disease on survival

(2008) Marcelo C. Pasquini   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

No increased trapping of multipotent mesenchymal stromal cells in bone marrow filters compared with other bone marrow cells

(2008) M. Sundin et al.   CYTOTHERAPY

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET